← Leaderboards
Marcelo R Vargas
University Of Wisconsin-Madison
$6,580,903
Attributed
$6,580,903
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $744.4K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,580,903 · 5
By mechanism
R01$5,337,818 · 2
R00$747,000 · 1
R21$406,085 · 1
K99$90,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Dudley William Lamming$11,752,625
- Randolph S Ashton$2,924,803
- Christy A Barlow$139,457
- Shaoqin - Gong$18,047,338
Others in their field
Top investigators on “Link”
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- David R. Weir · University Of Michigan At Ann Arbor$206,261,870
- Clare E Reimers · Gordon Research Conferences$205,233,456
- Demian A Bailey · Oregon State University$205,233,456
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
Research focus
LinkAstrocytesSpinal CordCoculture TechniquesNerve DegenerationParalysedMovementMouse ModelMusclePhenotypeUnited StatesAmyotrophic Lateral SclerosisMolecularDisease ProgressionAdultMotor Neuron DegenerationCessation Of LifeMotor NeuronsMutationInsightNeurogliaFamilial Amyotrophic Lateral SclerosisIn VivoMotor Cortex
Grant awards (23)
Role of FABP7 in ALS models$382,090
R01 · FY2025 · NS · contact PI
NAD+ metabolism and signaling in ALS models$362,295
R01 · FY2025 · NS · contact PI
Role of FABP7 in ALS models$370,627
R01 · FY2024 · NS · contact PI
Role of FABP7 in ALS models$382,090
R01 · FY2023 · NS · contact PI
NAD+ metabolism and signaling in ALS models$362,295
R01 · FY2023 · NS · contact PI
Role of FABP7 in ALS models$382,090
R01 · FY2022 · NS · contact PI
NAD+ metabolism and signaling in ALS models$362,295
R01 · FY2022 · NS · contact PI
Role of FABP7 in ALS models$382,090
R01 · FY2021 · NS · contact PI
NAD+ metabolism and signaling in ALS models$362,295
R01 · FY2021 · NS · contact PI
NAD+ metabolism and signaling in ALS models$361,339
R01 · FY2020 · NS · contact PI
NAD metabolism and mitochondrial dysfunction in ALS models$189,230
R01 · FY2019 · NS · contact PI
NAD metabolsim and mitochondrial dysfunction in ALS models$137,801
R01 · FY2019 · NS · contact PI
Circadian Timekeeping, Oxidative Stress and Metabolism in ALS Models$131,347
R21 · FY2019 · NS · contact PI
Circadian Timekeeping, Oxidative Stress and Metabolism in ALS Models$53,008
R21 · FY2019 · NS · contact PI
NAD metabolsim and mitochondrial dysfunction in ALS models$327,031
R01 · FY2018 · NS · contact PI
Circadian Timekeeping, Oxidative Stress and Metabolism in ALS Models$221,730
R21 · FY2018 · NS · contact PI
NAD metabolsim and mitochondrial dysfunction in ALS models$327,031
R01 · FY2017 · NS · contact PI
NAD metabolsim and mitochondrial dysfunction in ALS models$327,031
R01 · FY2016 · NS · contact PI
NAD metabolsim and mitochondrial dysfunction in ALS models$320,188
R01 · FY2015 · NS · contact PI
Glutathione in mitochondrial dysfunction and disease progression in ALS-models$249,000
R00 · FY2014 · ES · contact PI
Glutathione in mitochondrial dysfunction and disease progression in ALS-models$249,000
R00 · FY2013 · ES · contact PI
Glutathione in mitochondrial dysfunction and disease progression in ALS-models$249,000
R00 · FY2012 · ES · contact PI
Glutathione in mitochondrial dysfunction and disease progression in ALS-models$90,000
K99 · FY2011 · ES · contact PI